Financhill
Back

MEI Pharma Stock Predictions

MEI Pharma Stock Forecast

  • Is MEI Pharma Stock Undervalued?
    The current MEI Pharma [MEIP] share price is $3.13. The Score for MEIP is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • MEIP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will MEI Pharma Stock Go Up Next Year?

Data Unavailable

MEI Pharma Stock Rating

Data Unavailable

MEI Pharma Stock Price History

Is MEIP stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MEIP is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
meipharma.com

52-Week Data

52-Week High:
7.87
52-Week Low:
2.61

Prediction Charts

Market Cap:
20.85M
Price in USD:
3.13
Volume:
13.71K
Beta:
1.62

Technical Analysis

SMA50:
2.93
SMA100:
3.03
SMA200:
3.33
52-Wk Change:
-56.1%

Stock Predictions

  • Is MEI Pharma stock public?
    Yes, MEI Pharma is a publicly traded company.
  • What is the MEI Pharma stock quote today?
    The MEI Pharma stock price is 3.13 USD today.
  • How to buy MEI Pharma stock online?
    You can buy MEI Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-23 2.80 2.74 2.80 2.72
Oct-24 2.72 2.74 2.76 2.71
Oct-25 2.73 2.73 2.74 2.73
Oct-28 2.95 3.09 3.21 2.80
Oct-29 3.00 3.16 3.17 2.94
Oct-30 3.16 3.11 3.29 3.03
Oct-31 3.05 3.10 3.11 3.00
Nov-1 3.00 3.07 3.10 3.00
Nov-4 3.10 3.06 3.13 2.98
Nov-5 3.06 3.04 3.10 3.01
Nov-6 3.07 3.03 3.10 2.99
Nov-7 3.04 3.03 3.13 3.00
Nov-8 2.96 3.04 3.10 2.90
Nov-11 3.05 3.13 3.15 3.05

MEI Pharma Earnings

Data Unavailable

MEI Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.

* MEI Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.